Strata Oncology Secures $26 Million in Series B Funding, Led by Pfizer and Merck

Strata Oncology, a precision oncology platform company, today announced the close of a $26 million USD Series B funding round. New investors Pfizer Ventures, Merck Global Health Innovation Fund, Deerfield Management and Renaissance Venture Capital Fund were joined by existing investors Arboretum Ventures and Baird Capital.

Merck, Pfizer power tumor profiling firm Strata to $26M round – FierceBiotech Article